tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Stock Investors

394 Followers
Based on 728,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold SYRE
On average, investors allocate 2.66% of their portfolios to SYRE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,786 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding SYRE

2.8%
Last 7
Days
7.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding SYRE, out of 728,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

SYRE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.52%
$40.26
Based on the activity of 13,682 investors who made their portfolios public
The table shows changes in SYRE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

SYRE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.65%
-1.32%
-8.34%
245.00M
Healthcare
Assertio Therapeutics
2.64%
-1.24%
-9.06%
77.36M
Healthcare
DraftKings
7.19%
-1.26%
-3.57%
37.89B
Consumer Cyclical
GE Aerospace
5.53%
+1.08%
+6.09%
168.04B
Industrials
AMC Entertainment
5.42%
-1.38%
-6.90%
651.10M
Communication Services
Merck & Company
4.12%
-0.04%
-0.41%
319.59B
Healthcare
Marvell
4.86%
+1.81%
+7.70%
58.78B
Technology
Cisco Systems
4.55%
-0.81%
-5.21%
195.33B
Technology
Marathon Digital Holdings
5.39%
-0.26%
-3.45%
4.28B
Financial
CVS Health
4.14%
+0.03%
-5.35%
86.78B
Healthcare
Based on the activity of 728,786 active portfolios
Open your Smart Portfolio

SYRE Investor Analysis

SYRE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
4.9%
of SYRE holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
SYRE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
59.8%
of SYRE holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
SYRE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
35.4%
of SYRE holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of SYRE stock investors
See who invests in SYRE according to age group and performance.

FAQ

How many retail Investors hold SYRE?
<0.1% of TipRanks' retail investors hold SYRE in their portfolios.
    What is SYRE Investor Sentiment?
    SYRE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of SYRE in the last 7 days?
      ▲ 2.8% of TipRanks' retail investors changed their holding of SYRE in the last 7 days.
        What percentage of retail investors changed their holding of SYRE in the last 30 days?
        ▼ 7.3% of TipRanks' retail investors changed their holding of SYRE in the last 30 days.
          What is the average age of retail investors who hold SYRE?
          The average age of SYRE Holders is between 35–55.
            What other stocks have SYRE investors also bought?
            SYRE Investors also bought CHRS, ASRT, DKNG, GE, AMC, MRK, MRVL, CSCO, MARA, CVS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis